Home
RSSAfter the request from Food and Drug Administration (FDA), drug giant Novartis Pharmaceuticals Corporation of East Hanover, New Jersey has withdrew Zelnorm from the market.
FDA’s this decision came after Novartis, the Swiss pharmaceutical company,...
Related Stories
Most Recent
Most Popular
Most Commented
1
Star It 
(0)
While sending my answers to yourstory.in today, I came across a question - “Do you have any tips to share with budding entrepreneurs?”. I thought this might...
made popular Jul 1 2009
An advertising campaign for a hotel in Amsterdam has proved that honesty is the best policy. When brands are blowing their own trumpets by describing their unique and...
made popular Jun 30 2009
The world’s central bankers have warned that the British economy faces relapsing into another recession – the much-feared “double dip”...
made popular Jun 30 2009
The Financial Times reports that American television will face a $2 billion lose in advertising revenue over the next four years due to competing video mediums....
made popular Jun 30 2009
I am coming across more and more people who are just working for the sake of working - whether the work is paying them well or keeping them busy. It’s the same...
made popular Jun 30 2009
Yes. News bloopers do happen. Every year. Some are real. Some are fake ones created for attracting some free attention. If this video is fake, it is a kind of...
made popular Jun 29 2009
The Economist has succeeded to catch some curious glances through this billboard. By shooting some questions, the billboard leaves the viewer groping for answers. The...
made popular Jun 29 2009
Baci perugina, the chocolate brand in Italy, banks on love and romance to make it sweet and tempting. In its integrated campaign, the chocolate brand decided to sell...
made popular Jun 28 2009
Well-known high street furniture store Habitat has issued an apology (via its PR company, via a social media blog) for its misuse of popular hashtags on Twitter over...
made popular Jun 24 2009
The discussion around the Chris Anderson goof episode raises an interesting issue.
Is WordPress.com bad for the WordPress brand?
Think I am being to strong? Check out...
made popular Jun 24 2009
Tired of reading shocking headlines? Then, here is good news for you. Yes, good news, literally. Sears and AOL have launched GNN.com, which handles only feel good...
made popular Jun 24 2009
After the success of its first Startup event in Bangalore, Xtreme Startups team is excited to invite you to the 2nd edition of Startup Morning on 27th June, 2009 at...
made popular Jun 24 2009
If you are in the startup and technology circle, you must have definitely heard of Y Combinator’s Paul Graham. I came across this really good article about him...
made popular Jun 24 2009
Europe and the United States announced last night co-ordinated action against China for busting World Trade Organisation (WTO) rules by restricting exports of essential...
made popular Jun 24 2009
Is business a bad word? What will be your opinion while watching this commercial supporting Aung San Suu Kyi, the Nobel Peace Prize winner who has been imprisoned in...
made popular Jun 24 2009
One of the best, and FREE methods for advertising your website on the internet is via what has become known as the Web 2.0 phenomenom. Web 2.0 involves the formulation...
made popular Jun 22 2009
The one word that popped in my head after I watched Star Trek yesterday was ‘Teamwork’. Each and every one on USS Enterprise worked towards a common goal of...
made popular Jun 21 2009
The Union Cabinet has approved amendments in section 15N of the Securities & Exchange Board of India (SEBI) Act, 1992, by which the upper age limit of Members of...
made popular Jun 20 2009
The Union Cabinet has approved the text of a new memorandum of understanding (MoU) to be signed between India and United Kingdom on mutual administrative assistance to...
made popular Jun 20 2009
Merchants in China say that American and European orders for the holiday season, for which sweaters are just starting to be knit, have fallen by as much as 30 percent....
made popular Jun 20 2009
All Stories
Most Recent
Most Popular
Most Commented
AP, Geneva
Pharmaceuticals maker Novartis AG reported Thursday a 14 percent decline in first-quarter net profit in part due to shifts in currency values as well as the cost of...
made popular Apr 23 2009
AP, Dakar
Swiss pharmaceutical company Novartis is launching a new cherry-flavored malaria drug that it says children will be less likely to spit out.
made popular Feb 20 2009
AP, Basel
Drugmaker Novartis AG reported a 62 percent rise in fourth quarter net profit Wednesday, helped by steady sales growth and the absence of the restructuring charges that...
made popular Jan 28 2009
AP, Basel
Novartis AG said Wednesday it has received approval in Japan to market four drugs to treat asthma, cancer, hypertension and blindness.
made popular Jan 21 2009
AP, Basel
Swiss pharmaceutical giant Novartis AG said Thursday it has secured a $486 million contract to build a new flu vaccine plant in the United States.
made popular Jan 15 2009
AP, Basel
Swiss pharmaceutical giant Novartis AG said Monday it has licensed a potential vaccine for a type of herpes virus from U.S.-based company AlphaVax Inc.
made popular Dec 29 2008
AP, Washington
Federal regulators said Monday a combination drug from Novartis to treat malaria works better than older drugs already on the market.
made popular Dec 1 2008
AP, Basel
Pharmaceutical giant Novartis AG said Tuesday it will buy the pulmonary drug unit of California-based Nektar Therapeutics for $115 million.
made popular Oct 21 2008
AP, Basel
Drug maker Novartis AG on Monday reported a 32-percent rise in net profit for the third quarter due to strong sales and the positive impact from a weak U.S. dollar.
made popular Oct 20 2008
AP, Basel
Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.Net income rose...
made popular Jul 17 2008
AP, Basel
Novartis AG said Tuesday it has completed the first stage of its $38 billion takeover of U.S. eye-care company Alcon Inc.The Swiss pharmaceuticals company paid current...
made popular Jul 8 2008
AP, Washington
Health regulators reiterated their warning Friday that organ transplant drugs from Roche and Novartis can cause miscarriages and birth defects when used by pregnant...
made popular May 16 2008
AP, Basel
Pharmaceuticals maker Novartis AG reported a 7 percent rise in first-quarter profits Monday on the back of a declining dollar and solid performance in its vaccines and...
made popular Apr 21 2008
AP, Washington
Regulators are exploring whether organ transplant drugs made by Roche and Novartis increase the risk of an often-fatal neurological disease.The Food and Drug...
made popular Apr 10 2008
AP, Geneva
Switzerland’s Novartis AG said Monday it will spend about $39 billion in a two-step bid for a majority stake in U.S. eye-care company Alcon.The deal for Alcon...
made popular Apr 7 2008
AP, Basel
Switzerland’s Novartis AG said Monday it will spend about $38 billion in a two-step bid for a majority stake in U.S. eye-care company Alcon.The pharmaceutical...
made popular Apr 7 2008
AP, Basel
Novartis AG will cut 2,500 jobs worldwide by 2010 in an attempt to save $1.6 billion, the drug maker said Thursday.The company said it would take a restructuring charge...
made popular Dec 13 2007
AP, Washington
In the headline of an Oct. 29 story about the FDA’s approval of a new leukemia drug, The Associated Press misspelled the name of the company and the disease. The...
made popular Oct 30 2007
AP, Washington
A second-line drug to treat a life-threatening form of leukemia has won federal approval, the Food and Drug Administration said Monday.Tasigna, known generically as...
made popular Oct 29 2007
AP, Basel
The drugmaker Novartis AG said Monday that the European Commission had approved its Exelon skin patch to treat Alzheimer’s disease.The patch, which was approved...
made popular Sep 24 2007
Related Tags
Alcon Basel Business Drug earns EU Europe FDA Health & Fitness Leukemia North America Novartis AG Pictorial Roche swiss Switzerland Technology U.S. United States Washington
Images
Basel:
In this Dec. 13, 2007 file picture, a building of Swiss pharmaceutical company Novartis is shown in Basel, Switzerland. Novartis AG said Thursday July 10, 2008 it has acquired a majority of shares in Swiss pharmaceutical maker Speedel Holding AG and...
